United States · Bill · S
S. 1221 (111th)
A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Introduced
9 June 2009
Last action
—
Status
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S6384)
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 9 June 2009
Introduced in Senate (PDF)
Introduced in Senate · EN · 9 June 2009
Introduced in Senate
summary · EN · 9 June 2009
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/111th-congress/senate-bill/1221
- Open data entity: https://api.congress.gov/v3/bill/111/s/1221